img

Global Prescription Pain Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prescription Pain Medications Market Insights, Forecast to 2034

The global Prescription Pain Medications market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Prescription Pain Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Prescription Pain Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Prescription Pain Medications is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key manufacturers of Prescription Pain Medications include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes


This report presents an overview of global market for Prescription Pain Medications, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Prescription Pain Medications, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Prescription Pain Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prescription Pain Medications sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2024. Identification of the major stakeholders in the global Prescription Pain Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2034. Evaluation and forecast the market size for Prescription Pain Medications sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc.



By Company


Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Teva
J&J
Allergan
Segment by Type
Prescription NSAIDs
Opioids
Anti-epileptic Medicines
Antidepressants
Others

Segment by Application


Hospitals
Clinics
Drugstores
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Prescription Pain Medications in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3Detailed analysis of Prescription Pain Medications manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8China by type, by application sales and revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Pain Medications sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Study Coverage
1.1 Prescription Pain Medications Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Pain Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Prescription NSAIDs
1.2.3 Opioids
1.2.4 Anti-epileptic Medicines
1.2.5 Antidepressants
1.2.6 Others
1.3 Market by Application
1.3.1 Global Prescription Pain Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Drugstores
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Prescription Pain Medications Sales Estimates and Forecasts 2018-2034
2.2 Global Prescription Pain Medications Revenue by Region
2.2.1 Global Prescription Pain Medications Revenue by Region: 2018 VS 2022 VS 2034
2.2.2 Global Prescription Pain Medications Revenue by Region (2018-2024)
2.2.3 Global Prescription Pain Medications Revenue by Region (2024-2034)
2.2.4 Global Prescription Pain Medications Revenue Market Share by Region (2018-2034)
2.3 Global Prescription Pain Medications Sales Estimates and Forecasts 2018-2034
2.4 Global Prescription Pain Medications Sales by Region
2.4.1 Global Prescription Pain Medications Sales by Region: 2018 VS 2022 VS 2034
2.4.2 Global Prescription Pain Medications Sales by Region (2018-2024)
2.4.3 Global Prescription Pain Medications Sales by Region (2024-2034)
2.4.4 Global Prescription Pain Medications Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Prescription Pain Medications Sales by Manufacturers
3.1.1 Global Prescription Pain Medications Sales by Manufacturers (2018-2024)
3.1.2 Global Prescription Pain Medications Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Pain Medications in 2022
3.2 Global Prescription Pain Medications Revenue by Manufacturers
3.2.1 Global Prescription Pain Medications Revenue by Manufacturers (2018-2024)
3.2.2 Global Prescription Pain Medications Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Pain Medications Revenue in 2022
3.3 Global Key Players of Prescription Pain Medications, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Prescription Pain Medications Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Prescription Pain Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Prescription Pain Medications, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Prescription Pain Medications, Product Offered and Application
3.8 Global Key Manufacturers of Prescription Pain Medications, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Pain Medications Sales by Type
4.1.1 Global Prescription Pain Medications Historical Sales by Type (2018-2024)
4.1.2 Global Prescription Pain Medications Forecasted Sales by Type (2024-2034)
4.1.3 Global Prescription Pain Medications Sales Market Share by Type (2018-2034)
4.2 Global Prescription Pain Medications Revenue by Type
4.2.1 Global Prescription Pain Medications Historical Revenue by Type (2018-2024)
4.2.2 Global Prescription Pain Medications Forecasted Revenue by Type (2024-2034)
4.2.3 Global Prescription Pain Medications Revenue Market Share by Type (2018-2034)
4.3 Global Prescription Pain Medications Price by Type
4.3.1 Global Prescription Pain Medications Price by Type (2018-2024)
4.3.2 Global Prescription Pain Medications Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Prescription Pain Medications Sales by Application
5.1.1 Global Prescription Pain Medications Historical Sales by Application (2018-2024)
5.1.2 Global Prescription Pain Medications Forecasted Sales by Application (2024-2034)
5.1.3 Global Prescription Pain Medications Sales Market Share by Application (2018-2034)
5.2 Global Prescription Pain Medications Revenue by Application
5.2.1 Global Prescription Pain Medications Historical Revenue by Application (2018-2024)
5.2.2 Global Prescription Pain Medications Forecasted Revenue by Application (2024-2034)
5.2.3 Global Prescription Pain Medications Revenue Market Share by Application (2018-2034)
5.3 Global Prescription Pain Medications Price by Application
5.3.1 Global Prescription Pain Medications Price by Application (2018-2024)
5.3.2 Global Prescription Pain Medications Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Prescription Pain Medications Market Size by Type
6.1.1 US & Canada Prescription Pain Medications Sales by Type (2018-2034)
6.1.2 US & Canada Prescription Pain Medications Revenue by Type (2018-2034)
6.2 US & Canada Prescription Pain Medications Market Size by Application
6.2.1 US & Canada Prescription Pain Medications Sales by Application (2018-2034)
6.2.2 US & Canada Prescription Pain Medications Revenue by Application (2018-2034)
6.3 US & Canada Prescription Pain Medications Market Size by Country
6.3.1 US & Canada Prescription Pain Medications Revenue by Country: 2018 VS 2022 VS 2034
6.3.2 US & Canada Prescription Pain Medications Sales by Country (2018-2034)
6.3.3 US & Canada Prescription Pain Medications Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Prescription Pain Medications Market Size by Type
7.1.1 Europe Prescription Pain Medications Sales by Type (2018-2034)
7.1.2 Europe Prescription Pain Medications Revenue by Type (2018-2034)
7.2 Europe Prescription Pain Medications Market Size by Application
7.2.1 Europe Prescription Pain Medications Sales by Application (2018-2034)
7.2.2 Europe Prescription Pain Medications Revenue by Application (2018-2034)
7.3 Europe Prescription Pain Medications Market Size by Country
7.3.1 Europe Prescription Pain Medications Revenue by Country: 2018 VS 2022 VS 2034
7.3.2 Europe Prescription Pain Medications Sales by Country (2018-2034)
7.3.3 Europe Prescription Pain Medications Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Prescription Pain Medications Market Size
8.1.1 China Prescription Pain Medications Sales (2018-2034)
8.1.2 China Prescription Pain Medications Revenue (2018-2034)
8.2 China Prescription Pain Medications Market Size by Application
8.2.1 China Prescription Pain Medications Sales by Application (2018-2034)
8.2.2 China Prescription Pain Medications Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Prescription Pain Medications Market Size by Type
9.1.1 Asia Prescription Pain Medications Sales by Type (2018-2034)
9.1.2 Asia Prescription Pain Medications Revenue by Type (2018-2034)
9.2 Asia Prescription Pain Medications Market Size by Application
9.2.1 Asia Prescription Pain Medications Sales by Application (2018-2034)
9.2.2 Asia Prescription Pain Medications Revenue by Application (2018-2034)
9.3 Asia Prescription Pain Medications Sales by Region
9.3.1 Asia Prescription Pain Medications Revenue by Region: 2018 VS 2022 VS 2034
9.3.2 Asia Prescription Pain Medications Revenue by Region (2018-2034)
9.3.3 Asia Prescription Pain Medications Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Prescription Pain Medications Market Size by Type
10.1.1 Middle East, Africa and Latin America Prescription Pain Medications Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Prescription Pain Medications Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Prescription Pain Medications Market Size by Application
10.2.1 Middle East, Africa and Latin America Prescription Pain Medications Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Prescription Pain Medications Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Prescription Pain Medications Sales by Country
10.3.1 Middle East, Africa and Latin America Prescription Pain Medications Revenue by Country: 2018 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Prescription Pain Medications Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Prescription Pain Medications Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Pfizer Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 GSK
11.2.1 GSK Company Information
11.2.2 GSK Overview
11.2.3 GSK Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 GSK Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Grunenthal
11.3.1 Grunenthal Company Information
11.3.2 Grunenthal Overview
11.3.3 Grunenthal Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grunenthal Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grunenthal Recent Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Overview
11.4.3 Bayer Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bayer Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sanofi Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Eli Lilly Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 AstraZeneca Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 Endo
11.8.1 Endo Company Information
11.8.2 Endo Overview
11.8.3 Endo Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Endo Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Endo Recent Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck Overview
11.9.3 Merck Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Merck Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Depomed
11.10.1 Depomed Company Information
11.10.2 Depomed Overview
11.10.3 Depomed Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Depomed Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Depomed Recent Developments
11.11 Teva
11.11.1 Teva Company Information
11.11.2 Teva Overview
11.11.3 Teva Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Teva Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Recent Developments
11.12 J&J
11.12.1 J&J Company Information
11.12.2 J&J Overview
11.12.3 J&J Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 J&J Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 J&J Recent Developments
11.13 Allergan
11.13.1 Allergan Company Information
11.13.2 Allergan Overview
11.13.3 Allergan Prescription Pain Medications Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Allergan Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Allergan Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Pain Medications Industry Chain Analysis
12.2 Prescription Pain Medications Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Pain Medications Production Mode & Process
12.4 Prescription Pain Medications Sales and Marketing
12.4.1 Prescription Pain Medications Sales Channels
12.4.2 Prescription Pain Medications Distributors
12.5 Prescription Pain Medications Customers
13 Market Dynamics
13.1 Prescription Pain Medications Industry Trends
13.2 Prescription Pain Medications Market Drivers
13.3 Prescription Pain Medications Market Challenges
13.4 Prescription Pain Medications Market Restraints
14 Key Findings in The Global Prescription Pain Medications Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Prescription Pain Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Prescription NSAIDs
Table 3. Major Manufacturers of Opioids
Table 4. Major Manufacturers of Anti-epileptic Medicines
Table 5. Major Manufacturers of Antidepressants
Table 6. Major Manufacturers of Others
Table 7. Global Prescription Pain Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Prescription Pain Medications Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Prescription Pain Medications Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Prescription Pain Medications Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Prescription Pain Medications Revenue Market Share by Region (2018-2024)
Table 12. Global Prescription Pain Medications Revenue Market Share by Region (2024-2034)
Table 13. Global Prescription Pain Medications Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 14. Global Prescription Pain Medications Sales by Region (2018-2024) & (K Units)
Table 15. Global Prescription Pain Medications Sales by Region (2024-2034) & (K Units)
Table 16. Global Prescription Pain Medications Sales Market Share by Region (2018-2024)
Table 17. Global Prescription Pain Medications Sales Market Share by Region (2024-2034)
Table 18. Global Prescription Pain Medications Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Prescription Pain Medications Sales Share by Manufacturers (2018-2024)
Table 20. Global Prescription Pain Medications Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Prescription Pain Medications Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Prescription Pain Medications, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Prescription Pain Medications Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Prescription Pain Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Prescription Pain Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Pain Medications as of 2022)
Table 26. Global Key Manufacturers of Prescription Pain Medications, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Prescription Pain Medications, Product Offered and Application
Table 28. Global Key Manufacturers of Prescription Pain Medications, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 31. Global Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 32. Global Prescription Pain Medications Sales Share by Type (2018-2024)
Table 33. Global Prescription Pain Medications Sales Share by Type (2024-2034)
Table 34. Global Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Prescription Pain Medications Revenue Share by Type (2018-2024)
Table 37. Global Prescription Pain Medications Revenue Share by Type (2024-2034)
Table 38. Prescription Pain Medications Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Prescription Pain Medications Price Forecast by Type (2024-2034) & (US$/Unit)
Table 40. Global Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 41. Global Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 42. Global Prescription Pain Medications Sales Share by Application (2018-2024)
Table 43. Global Prescription Pain Medications Sales Share by Application (2024-2034)
Table 44. Global Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Prescription Pain Medications Revenue Share by Application (2018-2024)
Table 47. Global Prescription Pain Medications Revenue Share by Application (2024-2034)
Table 48. Prescription Pain Medications Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Prescription Pain Medications Price Forecast by Application (2024-2034) & (US$/Unit)
Table 50. US & Canada Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 52. US & Canada Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 54. US & Canada Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 56. US & Canada Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 58. US & Canada Prescription Pain Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. US & Canada Prescription Pain Medications Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Prescription Pain Medications Revenue by Country (2024-2034) & (US$ Million)
Table 61. US & Canada Prescription Pain Medications Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Prescription Pain Medications Sales by Country (2024-2034) & (K Units)
Table 63. Europe Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 64. Europe Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 65. Europe Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 67. Europe Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 68. Europe Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 69. Europe Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 71. Europe Prescription Pain Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 72. Europe Prescription Pain Medications Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Prescription Pain Medications Revenue by Country (2024-2034) & (US$ Million)
Table 74. Europe Prescription Pain Medications Sales by Country (2018-2024) & (K Units)
Table 75. Europe Prescription Pain Medications Sales by Country (2024-2034) & (K Units)
Table 76. China Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 77. China Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 78. China Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 80. China Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 81. China Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 82. China Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 84. Asia Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 85. Asia Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 86. Asia Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 88. Asia Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 89. Asia Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 90. Asia Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 92. Asia Prescription Pain Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 93. Asia Prescription Pain Medications Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Prescription Pain Medications Revenue by Region (2024-2034) & (US$ Million)
Table 95. Asia Prescription Pain Medications Sales by Region (2018-2024) & (K Units)
Table 96. Asia Prescription Pain Medications Sales by Region (2024-2034) & (K Units)
Table 97. Middle East, Africa and Latin America Prescription Pain Medications Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Prescription Pain Medications Sales by Type (2024-2034) & (K Units)
Table 99. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Type (2024-2034) & (US$ Million)
Table 101. Middle East, Africa and Latin America Prescription Pain Medications Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Prescription Pain Medications Sales by Application (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Application (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Prescription Pain Medications Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 106. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Prescription Pain Medications Revenue by Country (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Prescription Pain Medications Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Prescription Pain Medications Sales by Country (2024-2034) & (K Units)
Table 110. Pfizer Company Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Pfizer Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. GSK Company Information
Table 116. GSK Description and Major Businesses
Table 117. GSK Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. GSK Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. GSK Recent Developments
Table 120. Grunenthal Company Information
Table 121. Grunenthal Description and Major Businesses
Table 122. Grunenthal Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Grunenthal Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Grunenthal Recent Developments
Table 125. Bayer Company Information
Table 126. Bayer Description and Major Businesses
Table 127. Bayer Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Bayer Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bayer Recent Developments
Table 130. Sanofi Company Information
Table 131. Sanofi Description and Major Businesses
Table 132. Sanofi Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Sanofi Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Sanofi Recent Developments
Table 135. Eli Lilly Company Information
Table 136. Eli Lilly Description and Major Businesses
Table 137. Eli Lilly Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Eli Lilly Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Eli Lilly Recent Developments
Table 140. AstraZeneca Company Information
Table 141. AstraZeneca Description and Major Businesses
Table 142. AstraZeneca Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. AstraZeneca Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. AstraZeneca Recent Developments
Table 145. Endo Company Information
Table 146. Endo Description and Major Businesses
Table 147. Endo Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Endo Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Endo Recent Developments
Table 150. Merck Company Information
Table 151. Merck Description and Major Businesses
Table 152. Merck Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Merck Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Merck Recent Developments
Table 155. Depomed Company Information
Table 156. Depomed Description and Major Businesses
Table 157. Depomed Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Depomed Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Depomed Recent Developments
Table 160. Teva Company Information
Table 161. Teva Description and Major Businesses
Table 162. Teva Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Teva Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 164. Teva Recent Developments
Table 165. J&J Company Information
Table 166. J&J Description and Major Businesses
Table 167. J&J Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. J&J Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 169. J&J Recent Developments
Table 170. Allergan Company Information
Table 171. Allergan Description and Major Businesses
Table 172. Allergan Prescription Pain Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Allergan Prescription Pain Medications Product Model Numbers, Pictures, Descriptions and Specifications
Table 174. Allergan Recent Developments
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Prescription Pain Medications Distributors List
Table 178. Prescription Pain Medications Customers List
Table 179. Prescription Pain Medications Market Trends
Table 180. Prescription Pain Medications Market Drivers
Table 181. Prescription Pain Medications Market Challenges
Table 182. Prescription Pain Medications Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Prescription Pain Medications Product Picture
Figure 2. Global Prescription Pain Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Prescription Pain Medications Market Share by Type in 2022 & 2034
Figure 4. Prescription NSAIDs Product Picture
Figure 5. Opioids Product Picture
Figure 6. Anti-epileptic Medicines Product Picture
Figure 7. Antidepressants Product Picture
Figure 8. Others Product Picture
Figure 9. Global Prescription Pain Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Prescription Pain Medications Market Share by Application in 2022 & 2034
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. Drugstores
Figure 14. Others
Figure 15. Prescription Pain Medications Report Years Considered
Figure 16. Global Prescription Pain Medications Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 17. Global Prescription Pain Medications Revenue 2018-2034 (US$ Million)
Figure 18. Global Prescription Pain Medications Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 19. Global Prescription Pain Medications Revenue Market Share by Region (2018-2034)
Figure 20. Global Prescription Pain Medications Sales 2018-2034 ((K Units)
Figure 21. Global Prescription Pain Medications Sales Market Share by Region (2018-2034)
Figure 22. US & Canada Prescription Pain Medications Sales YoY (2018-2034) & (K Units)
Figure 23. US & Canada Prescription Pain Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 24. Europe Prescription Pain Medications Sales YoY (2018-2034) & (K Units)
Figure 25. Europe Prescription Pain Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 26. China Prescription Pain Medications Sales YoY (2018-2034) & (K Units)
Figure 27. China Prescription Pain Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Asia (excluding China) Prescription Pain Medications Sales YoY (2018-2034) & (K Units)
Figure 29. Asia (excluding China) Prescription Pain Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 30. Middle East, Africa and Latin America Prescription Pain Medications Sales YoY (2018-2034) & (K Units)
Figure 31. Middle East, Africa and Latin America Prescription Pain Medications Revenue YoY (2018-2034) & (US$ Million)
Figure 32. The Prescription Pain Medications Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 33. The Top 5 and 10 Largest Manufacturers of Prescription Pain Medications in the World: Market Share by Prescription Pain Medications Revenue in 2022
Figure 34. Global Prescription Pain Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 35. Global Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 36. Global Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 37. Global Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 38. Global Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 39. US & Canada Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 40. US & Canada Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 41. US & Canada Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 42. US & Canada Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 43. US & Canada Prescription Pain Medications Revenue Share by Country (2018-2034)
Figure 44. US & Canada Prescription Pain Medications Sales Share by Country (2018-2034)
Figure 45. U.S. Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 48. Europe Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 49. Europe Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 50. Europe Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 51. Europe Prescription Pain Medications Revenue Share by Country (2018-2034)
Figure 52. Europe Prescription Pain Medications Sales Share by Country (2018-2034)
Figure 53. Germany Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 54. France Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 58. China Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 59. China Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 60. China Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 61. China Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 62. Asia Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 63. Asia Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 64. Asia Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 65. Asia Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 66. Asia Prescription Pain Medications Revenue Share by Region (2018-2034)
Figure 67. Asia Prescription Pain Medications Sales Share by Region (2018-2034)
Figure 68. Japan Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 69. South Korea Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 70. China Taiwan Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 71. Southeast Asia Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 72. India Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Prescription Pain Medications Sales Market Share by Type (2018-2034)
Figure 74. Middle East, Africa and Latin America Prescription Pain Medications Revenue Market Share by Type (2018-2034)
Figure 75. Middle East, Africa and Latin America Prescription Pain Medications Sales Market Share by Application (2018-2034)
Figure 76. Middle East, Africa and Latin America Prescription Pain Medications Revenue Market Share by Application (2018-2034)
Figure 77. Middle East, Africa and Latin America Prescription Pain Medications Revenue Share by Country (2018-2034)
Figure 78. Middle East, Africa and Latin America Prescription Pain Medications Sales Share by Country (2018-2034)
Figure 79. Brazil Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 80. Mexico Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 81. Turkey Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 82. Israel Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 83. GCC Countries Prescription Pain Medications Revenue (2018-2034) & (US$ Million)
Figure 84. Prescription Pain Medications Value Chain
Figure 85. Prescription Pain Medications Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries